Evidence map›Paper›PMID 16789842›Full record

ArticlePLoS pathogens2006

Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.

Kelly B McClellan, Shivaprakash Gangappa, Samuel H Speck, Herbert W Virgin

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kelly B McClellanDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Shivaprakash Gangappa
Samuel H Speck
Herbert W Virgin
Emory University · USWashington University in St. Louis · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Regulation of Y-herpesvirus latency and tumorigenesisR01CA074730 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1998 to 2007
$2.8M
Vascular Injury and Atherosclerosis During Herpesvirus *R01HL060090 · NHLBI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1999 to 2005
$2.5M
KAPOSIS SARCOMA INDUCTION BY MURINE Y-HERPESVIRUS 68R55CA074730 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1997 to 1997
–
NCI NIH HHS CA74730NCI NIH HHS R01 CA074730NCI NIH HHS R01 CA74730NHLBI NIH HHS HL60090NHLBI NIH HHS R01 HL060090NIAID NIH HHS AI07163-27NIAID NIH HHS T32 AI007163NIAID NIH HHS T32AI07163
6 · The paper itself

Abstract

B cells can use antibody-dependent mechanisms to control latent viral infections. It is unknown whether this represents the sole function of B cells during chronic viral infection. We report here that hen egg lysozyme (HEL)-specific B cells can contribute to the control of murine gamma-herpesvirus 68 (gammaHV68) latency without producing anti-viral antibody. HEL-specific B cells normalized defects in T cell numbers and proliferation observed in B cell-/- mice during the early phase of gammaHV68 latency. HEL-specific B cells also reversed defects in CD8 and CD4 T cell cytokine production observed in B cell-/- mice, generating CD8 and CD4 T cells necessary for control of latency. Furthermore, HEL-specific B cells were able to present virally encoded antigen to CD8 T cells. Therefore, B cells have antibody independent functions, including antigen presentation, that are important for control of gamma-herpesvirus latency. Exploitation of this property of B cells may allow enhanced vaccine responses to chronic virus infection.

Indexed as

AnimalsAntibodies, ViralAntigen-Presenting CellsB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell CountCross ReactionsEpitopesGammaherpesvirinaeGenome, ViralImmunity, CellularLymphocyte ActivationMiceMice, Inbred StrainsMuramidaseAntibodies, ViralEpitopeshen egg lysozymeMuramidase

Identifiers

PMID16789842
PMCPMC1480598
OpenAlexW2072011749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.